Human HLA-DPB1 Ready-To-Use IHC Kit Size:50 Test Washington patent Anti-GAD65 Biosimilar) Specifications

Washington patent Anti-GAD65 Biosimilar) Specifications

but is likely to be of interest

q22) associated with T-cell acute lymphoblastic leukemia

GRP94 and its N-terminal fragment stimulates CTL expansion and maturation of human monocyte-derived dendritic cells (MDDC)

3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (Human prostate tumor) 1 slide RTU RT 13 Datasheet 1 copy

Human HLA-DPB1 Ready-To-Use IHC Kit Size:50 Test Washington patent Anti-GAD65 Biosimilar) SpecificationsHuman HLA DPB1 Ready To Use IHC Kit Cat. No.: IHC0617H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background HLA DPB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both